Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood-Brain Barrier Permeability: Implications for CNS Drug Design.

Molecules (Basel, Switzerland)·2026
Same author

Liposomal adrenaline for cardiopulmonary resuscitation: microfluidic production and pharmacokinetic analysis.

International journal of pharmaceutics·2025
Same author

Fatal acute intoxication after snorting cocaine and fluoxetine.

Legal medicine (Tokyo, Japan)·2025
Same author

Antitumor Activity, Mechanisms of Action and Phytochemical Profiling of Sub-Fractions Obtained from <i>Ulex gallii</i> Planch. (Fabaceae): A Medicinal Plant from Galicia (Spain).

Molecules (Basel, Switzerland)·2025
Same author

Seaweeds as Source of Bioactive Pigments with Neuroprotective and/or Anti-Neurodegenerative Activities: Astaxanthin and Fucoxanthin.

Marine drugs·2024
Same author

Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies.

Bioorganic chemistry·2024

Related Experiment Video

Updated: May 16, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Predicting monoamine oxidase inhibitory activity through ligand-based models.

Santiago Vilar1, Giulio Ferino, Elias Quezada

  • 1Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela 15782, Spain. qosanti@yahoo.es

Current Topics in Medicinal Chemistry
|December 13, 2012
PubMed
Summary

This study explores ligand-based computational methods to predict monoamine oxidase (MAO) enzyme inhibition. These in silico approaches aid in designing novel drug candidates for neurological disorders like Parkinson's and Alzheimer's disease.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Related Experiment Videos

Last Updated: May 16, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Area of Science:

  • Bioinformatics and Cheminformatics
  • Computational Drug Design
  • Medicinal Chemistry

Background:

  • In silico methods are increasingly vital for rational drug design, leveraging the principle that similar molecules share similar biological properties.
  • Ligand-based approaches predict molecular activity without requiring receptor structural data, focusing on 2D and 3D molecular properties.

Purpose of the Study:

  • To describe ligand-based computational models for predicting monoamine oxidase (MAO) inhibitory activity.
  • To investigate the structure-activity relationships of various chemical scaffolds as MAO inhibitors.
  • To explore enzyme selectivity and potential mechanisms of action for MAO inhibitors.

Main Methods:

  • Application of Quantitative Structure-Activity Relationship (QSAR) models using 2D and 3D descriptors.
  • Utilizing Comparative Molecular Field Analysis (CoMFA) and pharmacophoric approaches.
  • Synthesis and in vitro assay of diverse chemical scaffolds (coumarins, indolylmethylamines, pyridazines) for MAO-A and MAO-B inhibition.

Main Results:

  • Development and application of ligand-based models to predict MAO inhibitory activity.
  • Identification of key molecular features correlating with MAO inhibition across different scaffolds.
  • Comparative analysis of inhibitor efficacy against MAO-A and MAO-B isoforms.

Conclusions:

  • Ligand-based computational models offer valuable insights into the design of selective MAO inhibitors.
  • Understanding structure-activity relationships is crucial for developing effective treatments for neurological and psychiatric disorders.
  • Further research can refine these models for optimized drug discovery targeting MAO enzymes.